Table 2.
Ticagrelor 45 mg twice daily (n = 12) | Ticagrelor 60 mg twice daily (n = 12) | Ticagrelor 90 mg twice daily (n = 12) | |
---|---|---|---|
Patients with any AE, n (%) | 4 (33) | 4 (33) | 5 (42) |
Diarrhoea | 1 (8) | 1 (8) | 2 (17) |
Dyspnoea | 0 | 2 (17) | 1 (8) |
Hypoglycaemia | 1 (8) | 1 (8) | 0 |
Cardiac discomfort | 0 | 1 (8) | 1 (8) |
Blurred vision | 0 | 1 (8) | 0 |
Ventricular extrasystoles | 0 | 0 | 1 (8) |
Toothache | 0 | 0 | 1 (8) |
Tinea pedis | 1 (8) | 0 | 0 |
Palpitations | 0 | 1 (8) | 0 |
Pain in extremity | 0 | 0 | 1 (8) |
Positive occult blood | 1 (8) | 0 | 0 |
Non‐cardiac chest pain | 1 (8) | 0 | 0 |
Hyperhidrosis | 0 | 1 (8) | 0 |
Haemoptysis | 0 | 0 | 1 (8) |
Gingival bleeding | 0 | 1 (8) | 0 |
Frequent bowel movements | 0 | 0 | 1 (8) |
Epistaxis | 0 | 1 (8) | 0 |
Electrocardiogram ST‐T change | 0 | 1 (8) | 0 |
Constipation | 0 | 0 | 1 (8) |
AE, adverse event.